Clinical Trial Update: Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the effect of fingolimod on immune responses to seasonal influenza vaccination and tetanus booster in relapsing multiple sclerosis pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Fingolimod (fingolimod)

Snippet

Sponsor: Novartis | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-19